Somatic mutations in CREBBP and EP300are associated with a range of cancers3 germline CREBBP mutations and are linked with Rubinstein-Taybi syndrome(RTS).4 This syndrome is characterizedby growth impairment, learning difficulties, and distinctive facialand skeletal anomalies.5 RTS patients alsohave an increased likelihood of developing some forms of cancer. Here, CREBBP is linked to cancer.